Devoogdt; Nick

Patent Applications and Registrations

Patent applications and USPTO patent grants for Devoogdt; Nick.The latest application filed is for "human pd-l1-binding immunoglobulins".

Company Profile

3.9.15

Devoogdt; Nick - Eppegem-Zemst BE
Devoogdt; Nick - Eppegem BE
Devoogdt; Nick - Zemst BE
Devoogdt; Nick - Brussel BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Radiolabelled antibody fragments for use in treating cancer Grant 11,298,433 - Lahoutte , et al. April 12, 2	2022-04-12
Human Pd-l1-binding Immunoglobulins App 20210147546 - Van Ginderachter; Jo ; et al.	2021-05-20
Radio-labelled Antibody Fragments For Use In The Prognosis, Diagnosis Of Cancer As Well As For The Prediction Of Cancer Therapy App 20200276340 - Lahoutte; Tony ; et al.	2020-09-03
Cd20 Binding Agents And Uses Thereof App 20190077871 - Tavernier; Jan ; et al.	2019-03-14
Radiolabelled Antibody Fragments For Use In Treating Cancer App 20180200393 - LAHOUTTE; Tony ; et al.	2018-07-19
Targeting and in vivo imaging of tumor-associated macrophages Grant 9,913,920 - Movahedi , et al. March 13, 2	2018-03-13
Radio-labelled Antibody Fragments For Use In The Prognosis, Diagnosis Of Cancer As Well As For The Prediction Of Cancer Therapy Response App 20180036442 - Lahoutte; Tony ; et al.	2018-02-08
Radio-labelled antibody fragments for use in the prevention and/or treatment of cancer Grant 9,855,348 - Devoogdt , et al. January 2, 2	2018-01-02
Anti-VCAM-1 nanobodies Grant 9,771,423 - Ghezzi , et al. September 26, 2	2017-09-26
Method of imaging a cardiovascular disease with an anti-macrophage mannose receptor immunoglobulin single variable domain Grant 9,617,339 - De Baetselier , et al. April 11, 2	2017-04-11
Anti-macrophage mannose receptor single variable domains for targeting and in vivo imaging of tumor-associated macrophages Grant 9,556,273 - Van Ginderachter , et al. January 31, 2	2017-01-31
Radio-labelled Antibody Fragments For Use In The Prevention And/or Treatment Of Cancer App 20160030606 - Devoogdt; Nick ; et al.	2016-02-04
Anti-macrophage Mannose Receptor Single Variable Domains For Use In Cardiovascular Diseases App 20160024213 - De Baetselier; Patrick ; et al.	2016-01-28
Targeting And In Vivo Imaging Of Tumor-associated Macrophages App 20150335770 - Movahedi; Kiavash ; et al.	2015-11-26
Targeting and in vivo imaging of tumor-associated macrophages Grant 9,101,674 - Movahedi , et al. August 11, 2	2015-08-11
Anti-macrophage Mannose Receptor Single Variable Domains For Targeting And In Vivo Imaging Of Tumor-associated Macrophages App 20150093336 - Van Ginderachter; Jo ; et al.	2015-04-02
Anti-vcam-1 Nanobodies App 20140255303 - Ghezzi; Catherine ; et al.	2014-09-11
Targeting And In Vivo Imaging Of Tumor-associated Macrophages App 20120301394 - Movahedi; Kiavash ; et al.	2012-11-29
Selective targeting of intratumoral cells App 20110262348 - Movahedi; Kiavash ; et al.	2011-10-27
Use of a polypeptide domain to modulate the tumorigenic and metastatic potential of cancer cells App 20080199472 - Revets; Hilde ; et al.	2008-08-21
Use of a polypeptide domain to modulate the tumorigenic and metastatic potential of cancer cells App 20060111294 - Revets; Hilde ; et al.	2006-05-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.